13F-HR filed by ARCH Venture Management, LLC
ARCH Venture Management, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-13, with 7 holding rows worth $697,961,000.
- Accession
- 0001012975-22-000225
- Filer
- CIK 1274403
- Filed
- 2022-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 7 entries on the cover page, a total value of $697,961,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $697,961,000 with VALUE read as thousands by filing date, 13F file number 028-19358. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 2,912,872 | $369,323,000 | thousands by filing date | |
| EQRX INC | 26886C107 | COM | 36,335,375 | $150,065,000 | thousands by filing date | |
| ERASCA INC COM | 29479A108 | Stock | 11,055,554 | $95,078,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 2,508,809 | $57,251,000 | thousands by filing date | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 3,798,926 | $23,971,000 | thousands by filing date | |
| RUBIUS THERAPEUTICS INC | 78116T103 | COM | 349,908 | $1,928,000 | thousands by filing date | |
| ZYMERGEN INC | 98985X100 | COM | 119,205 | $345,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-22-000225 | this filing | 2022-05-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001012975-22-000255 | base | 2022-05-27 | acceptance time not in the bulk data set |